CompletedPhase 2NCT01160666

Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome

Studying Primary Sjögren disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Xavier Mariette, PhD
Rheumatology Department of BICETRE Hospital
Intervention
Belimumab(drug)
Enrollment
20 target
Eligibility
18 years · All sexes
Timeline
20102012

Study locations (1)

Collaborators

Human Genome Sciences Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01160666 on ClinicalTrials.gov

Other trials for Primary Sjögren disease

Additional recruiting or active studies for the same condition.

See all trials for Primary Sjögren disease

← Back to all trials